Class information for:
Level 1: ANAPLASTIC THYROID CARCINOMA//ANAPLASTIC THYROID CANCER//LENVATINIB

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
13109 860 37.6 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
139 3       THYROID//THYROID CANCER//GRAVES DISEASE 64904
301 2             THYROID CANCER//THYROID NODULE//PAPILLARY THYROID CARCINOMA 18583
13109 1                   ANAPLASTIC THYROID CARCINOMA//ANAPLASTIC THYROID CANCER//LENVATINIB 860

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANAPLASTIC THYROID CARCINOMA authKW 1203016 9% 45% 75
2 ANAPLASTIC THYROID CANCER authKW 1137129 8% 49% 66
3 LENVATINIB authKW 1000293 4% 78% 36
4 E7080 authKW 358005 1% 92% 11
5 ANAPLASTIC CARCINOMA authKW 255332 3% 26% 28
6 UNDIFFERENTIATED THYROID CANCER authKW 193301 1% 78% 7
7 ENDOCRINE NEOPLASIA HORMONAL DISORDERS address 152637 5% 11% 40
8 REFERENCE TUMEURS REFRACTAI THYROIDE address 147935 1% 83% 5
9 ADVANCED THYROID CANCER authKW 116192 1% 55% 6
10 CLM29 authKW 106514 0% 100% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 4395 38% 0% 323
2 Endocrinology & Metabolism 4278 28% 0% 238
3 Pathology 693 9% 0% 74
4 Surgery 436 14% 0% 120
5 Otorhinolaryngology 371 5% 0% 41
6 Pharmacology & Pharmacy 79 8% 0% 71
7 Medicine, General & Internal 48 5% 0% 45
8 Medical Laboratory Technology 40 1% 0% 12
9 Radiology, Nuclear Medicine & Medical Imaging 14 3% 0% 25
10 Microscopy 4 0% 0% 3

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ENDOCRINE NEOPLASIA HORMONAL DISORDERS 152637 5% 11% 40
2 REFERENCE TUMEURS REFRACTAI THYROIDE 147935 1% 83% 5
3 CONSORTIUM CANC THYROIDIEN 106514 0% 100% 3
4 NUCL MED ENDOCRINE ONCOL 95077 3% 11% 24
5 ISKUM 71010 0% 100% 2
6 ENDOCRINE MALIGNANCIES DIS ORIENTED GRP 63906 0% 60% 3
7 SERV MED NUCL ONCOL ENDOCRINIENNE 63906 0% 60% 3
8 SURG MED MOL PATHOL CRIT AREA 57249 1% 16% 10
9 CANC MEDUNIT 455 47338 0% 67% 2
10 HUMAN THYROID CANC PRECLIN TRANSLAT 47338 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 THYROID 32448 7% 2% 58
2 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 4478 6% 0% 55
3 ENDOCRINE-RELATED CANCER 2580 1% 1% 11
4 EUROPEAN JOURNAL OF ENDOCRINOLOGY 2197 2% 0% 18
5 HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 1635 2% 0% 15
6 CURRENT OPINION IN ONCOLOGY 1615 1% 1% 8
7 CANCER MANAGEMENT AND RESEARCH 1507 0% 2% 2
8 TARGETED ONCOLOGY 1368 0% 1% 4
9 MINERVA ENDOCRINOLOGICA 1115 0% 1% 3
10 ACTA CHIRURGICA AUSTRIACA 1108 0% 3% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ANAPLASTIC THYROID CARCINOMA 1203016 9% 45% 75 Search ANAPLASTIC+THYROID+CARCINOMA Search ANAPLASTIC+THYROID+CARCINOMA
2 ANAPLASTIC THYROID CANCER 1137129 8% 49% 66 Search ANAPLASTIC+THYROID+CANCER Search ANAPLASTIC+THYROID+CANCER
3 LENVATINIB 1000293 4% 78% 36 Search LENVATINIB Search LENVATINIB
4 E7080 358005 1% 92% 11 Search E7080 Search E7080
5 ANAPLASTIC CARCINOMA 255332 3% 26% 28 Search ANAPLASTIC+CARCINOMA Search ANAPLASTIC+CARCINOMA
6 UNDIFFERENTIATED THYROID CANCER 193301 1% 78% 7 Search UNDIFFERENTIATED+THYROID+CANCER Search UNDIFFERENTIATED+THYROID+CANCER
7 ADVANCED THYROID CANCER 116192 1% 55% 6 Search ADVANCED+THYROID+CANCER Search ADVANCED+THYROID+CANCER
8 CLM29 106514 0% 100% 3 Search CLM29 Search CLM29
9 THYROID CANCER 93525 10% 3% 85 Search THYROID+CANCER Search THYROID+CANCER
10 ANAPLASTIC 85988 2% 13% 19 Search ANAPLASTIC Search ANAPLASTIC

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BISOF, V , RAKUSIC, Z , DESPOT, M , (2015) TREATMENT OF PATIENTS WITH ANAPLASTIC THYROID CANCER DURING THE LAST 20 YEARS: WHETHER ANY PROGRESS HAS BEEN MADE?.EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. VOL. 272. ISSUE 7. P. 1553 -1567 64 94% 2
2 LENNON, P , DEADY, S , HEALY, ML , TONER, M , KINSELLA, J , TIMON, CI , O'NEILL, JP , (2016) ANAPLASTIC THYROID CARCINOMA: FAILURE OF CONVENTIONAL THERAPY BUT HOPE OF TARGETED THERAPY.HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. VOL. 38. ISSUE . P. E1122 -E1129 61 78% 0
3 ARE, C , SHAHA, AR , (2006) ANAPLASTIC THYROID CARCINOMA: BIOLOGY, PATHOGENESIS, PROGNOSTIC FACTORS, AND TREATMENT APPROACHES.ANNALS OF SURGICAL ONCOLOGY. VOL. 13. ISSUE 4. P. 453-464 58 66% 176
4 KWON, J , KIM, BH , JUNG, HW , BESIC, N , SUGITANI, I , WU, HG , (2016) THE PROGNOSTIC IMPACTS OF POSTOPERATIVE RADIOTHERAPY IN THE PATIENTS WITH RESECTED ANAPLASTIC THYROID CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.EUROPEAN JOURNAL OF CANCER. VOL. 59. ISSUE . P. 34 -45 39 85% 1
5 SMALLRIDGE, RC , ASA, SL , BIBLE, KC , BRIERLEY, JD , BURMAN, KD , KEBEBEW, E , LEE, NY , NIKIFOROV, YE , ROSENTHAL, MS , SHAH, MH , ET AL (2012) AMERICAN THYROID ASSOCIATION GUIDELINES FOR MANAGEMENT OF PATIENTS WITH ANAPLASTIC THYROID CANCER.THYROID. VOL. 22. ISSUE 11. P. 1104 -1139 73 37% 108
6 SMALLRIDGE, RC , (2012) APPROACH TO THE PATIENT WITH ANAPLASTIC THYROID CARCINOMA.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 97. ISSUE 8. P. 2566 -2572 37 88% 27
7 AKAISHI, J , SUGINO, K , KITAGAWA, W , NAGAHAMA, M , KAMEYAMA, K , SHIMIZU, K , ITO, K , ITO, K , (2011) PROGNOSTIC FACTORS AND TREATMENT OUTCOMES OF 100 CASES OF ANAPLASTIC THYROID CARCINOMA.THYROID. VOL. 21. ISSUE 11. P. 1183 -1189 36 84% 44
8 RAJHBEHARRYSINGH, U , TAYLOR, M , MILAS, M , (2014) MEDICAL THERAPY FOR ADVANCED FORMS OF THYROID CANCER.SURGICAL CLINICS OF NORTH AMERICA. VOL. 94. ISSUE 3. P. 541 -+ 44 70% 5
9 JIMENEZ-FONSECA, P , SAEZ, JMG , SANDI, JS , CAPDEVILA, J , GONZALEZ, EN , LLOPIS, CZ , ASENSIO, TRYC , RIESCO-EIZAGUIRRE, G , GRANDE, E , GALOFRE, JC , (2017) SPANISH CONSENSUS FOR THE MANAGEMENT OF PATIENTS WITH ANAPLASTIC CELL THYROID CARCINOMA.CLINICAL & TRANSLATIONAL ONCOLOGY. VOL. 19. ISSUE 1. P. 12 -20 39 76% 0
10 LEE, DY , WON, JK , LEE, SH , PARK, DJ , JUNG, KC , SUNG, MW , WU, HG , KIM, KH , PARK, YJ , HAH, JH , (2016) CHANGES OF CLINICOPATHOLOGIC CHARACTERISTICS AND SURVIVAL OUTCOMES OF ANAPLASTIC AND POORLY DIFFERENTIATED THYROID CARCINOMA.THYROID. VOL. 26. ISSUE 3. P. 404 -413 29 78% 4

Classes with closest relation at Level 1


Rank Class id link
1 3413 PAPILLARY THYROID CARCINOMA//RET PTC//BRAFV600E MUTATION
2 35790 FACS MQ//ABCG2 BCRP GENE//ADULT RESIDENT THYROID STEM PROGENITOR CELLS
3 13181 INSULAR CARCINOMA//HURTHLE CELL//HURTHLE CELL CARCINOMA
4 599 PAPILLARY THYROID CARCINOMA//THYROID CANCER//PAPILLARY THYROID CANCER
5 17312 SOLID CELL NESTS//THYROID METASTASIS//THYROID METASTASES
6 1110 MEDULLARY THYROID CARCINOMA//RET PROTO ONCOGENE//MEDULLARY THYROID CANCER
7 12694 SODIUM IODIDE SYMPORTER//SODIUM IODIDE SYMPORTER NIS//IODIDE TRANSPORT
8 18265 VANDETANIB//NINTEDANIB//CEDIRANIB
9 16482 THYROID LYMPHOMA//PRIMARY THYROID LYMPHOMA//HASHIMOTOS THYROIDITIS
10 2449 THYROGLOBULIN//DIFFERENTIATED THYROID CANCER//DIFFERENTIATED THYROID CARCINOMA

Go to start page